Nephrology and Hypertension Institute, Samson Assuta University Hospital, Ashdod, Israel.
Faculty of Health Sciences, Ben Gurion University of the Negev, Beer Sheva, Israel.
Isr Med Assoc J. 2022 Mar;24(3):165-169.
Hypertension and cancer are both common due to the aging of the population and the advances in medical treatment which result in increased survival of cancer patients today. More patients with cancer; therefore, present with hypertension, which is attributed to different factors, including genetics and age as well as the type of tumor and cancer-related treatments. Given the increased cardiovascular and mortality risk related to hypertension, it is important to appropriately identify and treat hypertension, particularly in the population of vulnerable cancer patients. In this article we discuss the epidemiology, different etiologies, and approaches to the management of hypertension in cancer patients.
高血压和癌症都是常见的疾病,这是由于人口老龄化和医疗技术的进步导致如今癌症患者的生存率提高所致。因此,更多的癌症患者患有高血压,这归因于不同的因素,包括遗传和年龄以及肿瘤类型和与癌症相关的治疗。鉴于高血压与心血管疾病和死亡率增加相关,因此重要的是要适当地识别和治疗高血压,特别是在脆弱的癌症患者群体中。在本文中,我们讨论了癌症患者中高血压的流行病学、不同病因和管理方法。